Chandra Bhagat Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve Un-audited result for ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Chandra Bhagat Pharma Ltd has informed BSE that its Board of Directors will meet on Thursday, 13 November 2025 at 5:00 PM at the registered office in Matunga East, Mumbai. The key item on the agenda is consideration and approval of the Un-Audited Financial Statements along with the Limited Review Report for the half year ended 30 September 2025 (H2 of FY25). The intimation is filed under Regulation 29 of SEBI LODR Regulations, 2015. No financial figures, comparisons, or outlook details have been disclosed in this notice — those will emerge once the board approves the results.
This is a routine regulatory intimation and not an earnings announcement. Shareholders should watch for the actual H1 FY26 results on or after 13 November 2025 to gauge the company's revenue growth, profitability, and margin trends. No immediate stock price trigger is expected from this notice alone.